461 - 470 of 4301 Drugs

Anthim (obiltoxaximab intravenous infusion)

Anthim (obiltoxaximab) injection is a monoclonal antibody directed against the protective antigen of Bacillus anthracis indicated in adult and pediatric patients for treatment of inhalational anthrax due to B. anthracis in combination with appropriate antibacterial drugs and, for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

Dritho-Scalp (anthralin)

Dritho-Scalp (anthralin) Topical Cream is an antipsoriatic medication used to treat long-term psoriasis of the scalp. Dritho-Scalp may be available in generic form.

Zithranol Cream (anthralin microcrystalline encapsulated cream)

Zithranol-RR (anthralin cream) is an antipsoriatic medication used to treat long-term psoriasis. Zithranol-RR is available in generic form.

Zithranol Shampoo (anthralin microcrystalline-encapsulated system, 1%)

Zithranol Shampoo (1% anthralin) is a topical anti-psoriatic medication indicated for the treatment of scalp psoriasis in subjects 12 years of age and older.

Anthrasil (anthrax immune globulin intravenous (human), sterile solution for infusion)

Anthrasil [anthrax immune globulin (human) liquid] is an anthrax immune globulin intravenous (human) indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs.

BioThrax (anthrax vaccine adsorbed emergent biosolutions)

BioThrax (anthrax) Vaccine Adsorbed is an immunization used to help prevent anthrax disease in people exposed to the bacteria through the skin or lungs. BioThrax vaccine works by exposing you to an antigen protein that causes your body to develop immunity to the disease. BioThrax does not contain live or killed forms of the bacteria that cause anthrax. BioThrax vaccine will not treat an active infection.

Cyfendus (anthrax vaccine adsorbed for injection)

Cyfendus (anthrax vaccine adsorbed, adjuvanted) is a vaccine indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs.

Feiba (anti-inhibitor coagulant complex for intravenous use)

Feiba (anti-inhibitor coagulant complex) is an anti-inhibitor coagulant complex indicated for use in hemophilia A and B patients with inhibitors for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Autoplex-T (anti-inhibitor coagulant complex, heat treated)

Autoplex T (anti-inhibitor coagulant complex, heat treated) is made from proteins normally found in human blood that allow the blood to clot and is used to treat or prevent bleeding in people with hemophilia A or B and Factor VIII inhibitors.

Feiba VH (anti-inhibitor coagulant complex, vapor heated)

Feiba VH (anti-inhibitor coagulant complex [AICC], vapor heated) is made up of proteins normally present in the blood that allow the blood to clot used to treat or prevent bleeding in people with hemophilia and Factor VIII inhibitors.


Users in supermaster role can add new drug entries